Product Code: ETC070903 | Publication Date: Jun 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The DNA Damage Response Drugs Market in India is expected to grow significantly during the forecast period, as a result of increasing incidence of genetic diseases and growing pharmaceutical research activities. The market is being driven by increased public awareness about the benefits of gene therapy, rising healthcare expenditure, technological advancements in genomic sequencing technologies and drug development platforms, and government initiatives to promote personalized medicine. Additionally, increasing geriatric population and availability of skilled professionals are also driving growth in this sector. Furthermore, with the emergence of Covid-19 pandemic there has been an increase demand for DNA damage response drugs which will further drive growth.
Increasing Incidence Of Genetic Diseases: India has seen an exponential rise in genetic disorders due to various environmental factors such as air pollution, radiation exposure etc., Hence the need for effective treatment strategies such as gene therapy has grown substantially over recent years leading to an increased demand for DNA repair drugs across India. Technological Advancements In Genomic Sequencing Technologies And Drug Development Platforms : With rapid advancement in technology especially with regards to genomics sequencing techniques along with development tools like CRISPR/Cas9 there have been tremendous improvements made towards better understanding disease mechanisms at molecular level which would go on to help develop effective treatments using precision medicines . This factor is expected to drive significant growth in this market. Government Initiatives To Promote Personalized Medicine : Governments across India have taken several measures such as implementation tax incentives , providing funding support etc., To encourage research & development activities in personalized medicines . This will foster greater penetration & acceptance among patients leading to an anticipated surge product sales over coming years contributing positively towards overall industry expansion.
High Cost Of Treatment: At present cost associated with gene based therapies are quite high when compared conventional medical treatments making it difficult for average family`s purchase these expensive medications . Thus , lack affordability remains one primary challenge facing this sector from achieving desired success rate over future timeline 2 ) Limited Number Of Skilled Professionals : There exists limited number qualified personnel who can carry out accurate diagnosis based upon patient?s genetic conditions along with understanding exact molecular mechanism behind particular disorder so that appropriate remedy be provided accordingly . This factor could potentially slow down progress within field owing shortage technical expertise available.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India DNA Damage Response Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India DNA Damage Response Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India DNA Damage Response Drugs Market - Industry Life Cycle |
3.4 India DNA Damage Response Drugs Market - Porter's Five Forces |
3.5 India DNA Damage Response Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India DNA Damage Response Drugs Market Revenues & Volume Share, By Applications, 2021 & 2031F |
4 India DNA Damage Response Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 India DNA Damage Response Drugs Market Trends |
6 India DNA Damage Response Drugs Market, By Types |
6.1 India DNA Damage Response Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India DNA Damage Response Drugs Market Revenues & Volume, By Type, 2018 - 2031F |
6.1.3 India DNA Damage Response Drugs Market Revenues & Volume, By PARP, 2018 - 2031F |
6.1.4 India DNA Damage Response Drugs Market Revenues & Volume, By Inhibitors, 2018 - 2031F |
6.1.5 India DNA Damage Response Drugs Market Revenues & Volume, By Others, 2018 - 2031F |
6.2 India DNA Damage Response Drugs Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 India DNA Damage Response Drugs Market Revenues & Volume, By Oncology, 2018 - 2031F |
6.2.3 India DNA Damage Response Drugs Market Revenues & Volume, By Stroke, 2018 - 2031F |
6.2.4 India DNA Damage Response Drugs Market Revenues & Volume, By Radiotherapy, 2018 - 2031F |
7 India DNA Damage Response Drugs Market Import-Export Trade Statistics |
7.1 India DNA Damage Response Drugs Market Export to Major Countries |
7.2 India DNA Damage Response Drugs Market Imports from Major Countries |
8 India DNA Damage Response Drugs Market Key Performance Indicators |
9 India DNA Damage Response Drugs Market - Opportunity Assessment |
9.1 India DNA Damage Response Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India DNA Damage Response Drugs Market Opportunity Assessment, By Applications, 2021 & 2031F |
10 India DNA Damage Response Drugs Market - Competitive Landscape |
10.1 India DNA Damage Response Drugs Market Revenue Share, By Companies, 2024 |
10.2 India DNA Damage Response Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |